These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24838249)

  • 1. ¹¹C-ORM-13070, a novel PET ligand for brain α₂C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men.
    Luoto P; Suilamo S; Oikonen V; Arponen E; Helin S; Herttuainen J; Hietamäki J; Holopainen A; Kailajärvi M; Peltonen JM; Rouru J; Sallinen J; Scheinin M; Virta J; Virtanen K; Volanen I; Roivainen A; Rinne JO
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1947-56. PubMed ID: 24838249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
    Arponen E; Helin S; Marjamäki P; Grönroos T; Holm P; Löyttyniemi E; Någren K; Scheinin M; Haaparanta-Solin M; Sallinen J; Solin O
    J Nucl Med; 2014 Jul; 55(7):1171-7. PubMed ID: 24799619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of [(11) C]ORM-13070 as a PET tracer for alpha2c -adrenoceptors in the human brain.
    Lehto J; Hirvonen MM; Johansson J; Kemppainen J; Luoto P; Naukkarinen T; Oikonen V; Arponen E; Rouru J; Sallinen J; Scheinin H; Vuorilehto L; Finnema SJ; Halldin C; Rinne JO; Scheinin M
    Synapse; 2015 Mar; 69(3):172-81. PubMed ID: 25530024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain.
    Lehto J; Virta JR; Oikonen V; Roivainen A; Luoto P; Arponen E; Helin S; Hietamäki J; Holopainen A; Kailajärvi M; Peltonen JM; Rouru J; Sallinen J; Virtanen K; Volanen I; Scheinin M; Rinne JO
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):120-7. PubMed ID: 25201008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and Radiation Dosimetry of
    Garg PK; Lokitz SJ; Nazih R; Garg S
    J Nucl Med; 2017 Mar; 58(3):473-478. PubMed ID: 27660145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-Humans Study of
    Viitanen R; Moisio O; Lankinen P; Li XG; Koivumäki M; Suilamo S; Tolvanen T; Taimen K; Mali M; Kohonen I; Koskivirta I; Oikonen V; Virtanen H; Santalahti K; Autio A; Saraste A; Pirilä L; Nuutila P; Knuuti J; Jalkanen S; Roivainen A
    J Nucl Med; 2021 Apr; 62(4):577-583. PubMed ID: 32817143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and radiation dosimetry in healthy volunteers of a novel tumour-specific probe for PET/CT imaging: BAY 85-8050.
    Smolarz K; Krause BJ; Graner FP; Wagner FM; Wester HJ; Sell T; Bacher-Stier C; Fels L; Dinkelborg L; Schwaiger M
    Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1861-8. PubMed ID: 23877631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand 11C-NOP-1A.
    Lohith TG; Zoghbi SS; Morse CL; Araneta MF; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
    J Nucl Med; 2012 Mar; 53(3):385-92. PubMed ID: 22312136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects.
    Miyamoto M; Okuyama C; Kagawa S; Kusano K; Takahashi M; Takahata K; Jang MK; Yamauchi H
    Ann Nucl Med; 2023 May; 37(5):300-309. PubMed ID: 36890399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry.
    Challapalli A; Kenny LM; Hallett WA; Kozlowski K; Tomasi G; Gudi M; Al-Nahhas A; Coombes RC; Aboagye EO
    J Nucl Med; 2013 Sep; 54(9):1551-6. PubMed ID: 23949910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting a dexmedetomidine-evoked reduction of noradrenaline release in the human brain with the alpha2C-adrenoceptor PET ligand [11C]ORM-13070.
    Lehto J; Scheinin A; Johansson J; Marjamäki P; Arponen E; Scheinin H; Scheinin M
    Synapse; 2016 Feb; 70(2):57-65. PubMed ID: 26562363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMM.
    Toyohara J; Sakata M; Oda K; Ishii K; Ito K; Hiura M; Fujinaga M; Yamasaki T; Zhang MR; Ishiwata K
    J Nucl Med; 2013 Aug; 54(8):1302-7. PubMed ID: 23804329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET-derived biodistribution and dosimetry of the benzodiazepine receptor-binding radioligand (11)C-(R)-PK11195 in children and adults.
    Kumar A; Muzik O; Chugani D; Chakraborty P; Chugani HT
    J Nucl Med; 2010 Jan; 51(1):139-44. PubMed ID: 20008990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetry and efficacy of a tau PET tracer [
    Ohnishi A; Akamatsu G; Ikari Y; Nishida H; Shimizu K; Matsumoto K; Aita K; Sasaki M; Yamamoto Y; Yamane T; Senda M
    Ann Nucl Med; 2023 Feb; 37(2):108-120. PubMed ID: 36411357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and Radiation Dosimetry for the Tau Tracer
    Hsiao IT; Lin KJ; Huang KL; Huang CC; Chen HS; Wey SP; Yen TC; Okamura N; Hsu JL
    J Nucl Med; 2017 Sep; 58(9):1498-1503. PubMed ID: 28336780
    [No Abstract]   [Full Text] [Related]  

  • 16. Biodistribution and radiation dosimetry of the A1 adenosine receptor ligand 18F-CPFPX determined from human whole-body PET.
    Herzog H; Elmenhorst D; Winz O; Bauer A
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1499-506. PubMed ID: 18373090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma pharmacokinetics, whole-body distribution, metabolism, and radiation dosimetry of 68Ga bombesin antagonist BAY 86-7548 in healthy men.
    Roivainen A; Kähkönen E; Luoto P; Borkowski S; Hofmann B; Jambor I; Lehtiö K; Rantala T; Rottmann A; Sipilä H; Sparks R; Suilamo S; Tolvanen T; Valencia R; Minn H
    J Nucl Med; 2013 Jun; 54(6):867-72. PubMed ID: 23564761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body biodistribution kinetics, metabolism, and radiation dosimetry estimates of 18F-PEG6-IPQA in nonhuman primates.
    Tian M; Ogawa K; Wendt R; Mukhopadhyay U; Balatoni J; Fukumitsu N; Uthamanthil R; Borne A; Brammer D; Jackson J; Mawlawi O; Yang B; Alauddin MM; Gelovani JG
    J Nucl Med; 2011 Jun; 52(6):934-41. PubMed ID: 21571803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.
    Doss M; Kolb HC; Walsh JC; Mocharla V; Fan H; Chaudhary A; Zhu Z; Alpaugh RK; Lango MN; Yu JQ
    J Nucl Med; 2013 Dec; 54(12):2087-92. PubMed ID: 24136934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolase.
    Boileau I; Bloomfield PM; Rusjan P; Mizrahi R; Mufti A; Vitcu I; Kish SJ; Houle S; Wilson AA; Tong J
    J Nucl Med; 2014 Dec; 55(12):1993-7. PubMed ID: 25413137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.